Literature DB >> 9102057

Who are candidates for prevention and treatment for osteoporosis?

.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9102057     DOI： 10.1007/bf01623453

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  31 in total

Review 1.  Hormone therapy to prevent disease and prolong life in postmenopausal women.

Authors:  D Grady; S M Rubin; D B Petitti; C S Fox; D Black; B Ettinger; V L Ernster; S R Cummings
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

2.  Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates.

Authors:  C W Slemenda; J C Christian; C J Williams; J A Norton; C C Johnston
Journal:  J Bone Miner Res       Date:  1991-06       Impact factor: 6.741

3.  A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women.

Authors:  M W Draper; D E Flowers; W J Huster; J A Neild; K D Harper; C Arnaud
Journal:  J Bone Miner Res       Date:  1996-06       Impact factor: 6.741

Review 4.  Clinical indications for bone mass measurements. A report from the Scientific Advisory Board of the National Osteoporosis Foundation.

Authors: 
Journal:  J Bone Miner Res       Date:  1989-11       Impact factor: 6.741

5.  Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy.

Authors:  B J Riis; K Overgaard; C Christiansen
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

6.  Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin.

Authors:  N A Morrison; R Yeoman; P J Kelly; J A Eisman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

7.  Prediction of bone density from vitamin D receptor alleles.

Authors:  N A Morrison; J C Qi; A Tokita; P J Kelly; L Crofts; T V Nguyen; P N Sambrook; J A Eisman
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

8.  Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; D M Black; M C Nevitt; W Browner; J Cauley; K Ensrud; H K Genant; L Palermo; J Scott; T M Vogt
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

9.  Low bone mass and fast rate of bone loss at menopause: equal risk factors for future fracture: a 15-year follow-up study.

Authors:  B J Riis; M A Hansen; A M Jensen; K Overgaard; C Christiansen
Journal:  Bone       Date:  1996-07       Impact factor: 4.398

10.  Rising incidence of fracture of the proximal femur.

Authors:  W J Boyce; M P Vessey
Journal:  Lancet       Date:  1985-01-19       Impact factor: 79.321
View more
  42 in total

Review 1.  Bone, inflammation, and inflammatory bowel disease.

Authors:  Manasi Agrawal; Shitij Arora; Jianjun Li; Rabin Rahmani; Li Sun; Adam F Steinlauf; Jeffrey I Mechanick; Mone Zaidi
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

Review 2.  Histone deacetylases in skeletal development and bone mass maintenance.

Authors:  Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Gene       Date:  2010-12-22       Impact factor: 3.688

3.  Adherence to treatment of primary osteoporosis and its association to fractures--the Swedish Adherence Register Analysis (SARA).

Authors:  E Landfeldt; O Ström; S Robbins; F Borgström
Journal:  Osteoporos Int       Date:  2011-02-01       Impact factor: 4.507

Review 4.  Alendronate: an update of its use in osteoporosis.

Authors:  M Sharpe; S Noble; C M Spencer
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Long-term stability and in vitro release of hPTH(1-34) from a multi-reservoir array.

Authors:  Elizabeth R Proos; James H Prescott; Mark A Staples
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

Review 6.  Is bone quality associated with collagen age?

Authors:  D J Leeming; K Henriksen; I Byrjalsen; P Qvist; S H Madsen; P Garnero; M A Karsdal
Journal:  Osteoporos Int       Date:  2009-03-28       Impact factor: 4.507

7.  Denosumab in postmenopausal osteoporosis: what the clinician needs to know.

Authors:  E Michael Lewiecki
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-02       Impact factor: 5.346

8.  Bisphosphonates for the treatment of osteoporosis: insights for clinicians.

Authors:  E Michael Lewiecki
Journal:  Ther Adv Chronic Dis       Date:  2010-05       Impact factor: 5.091

9.  Effects of exercise on bone mineral density in calcium-replete postmenopausal women with and without hormone replacement therapy.

Authors:  Scott Going; Timothy Lohman; Linda Houtkooper; Lauve Metcalfe; Hilary Flint-Wagner; Robert Blew; Vanessa Stanford; Ellen Cussler; Jane Martin; Pedro Teixeira; Margaret Harris; Laura Milliken; Arturo Figueroa-Galvez; Judith Weber
Journal:  Osteoporos Int       Date:  2003-07-03       Impact factor: 4.507

10.  Male osteoporosis: clinical approach and management in family practice.

Authors:  Lay Hoon Goh; Choon How How; Tang Ching Lau
Journal:  Singapore Med J       Date:  2014-07       Impact factor: 1.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.